Skip to main content
Erschienen in: Medical Oncology 5/2022

01.05.2022 | Original Paper

KRT15 promotes colorectal cancer cell migration and invasion through β-catenin/MMP-7 signaling pathway

verfasst von: Weida Chen, Chengli Miao

Erschienen in: Medical Oncology | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

KRT15 has been reported to act as an oncogene in colorectal cancer. However, whether KRT15 promotes colorectal cancer migration and invasion remain unclear. In this study, western blot and qRT-PCR assay were used to determine the expression of KRT15 in colorectal cancer cells. Wound-healing and transwell migration assay were performed to assess the migration of colorectal cancer cells. Matrigel transwell invasion assay was employed to examine the invasion of colorectal cancer cells. We found that KRT15 was highly expressed in colorectal cancer cells. Ectopic expression of KRT15 dramatically promoted colorectal cancer cell migration and invasion. Conversely, silencing KRT15 remarkably suppressed the migration and invasion of colorectal cancer cells. Importantly, we found that MMP-7 was crucial for KRT15-induced migration and invasion of colorectal cancer cells. Knockdown of MMP-7 significantly diminished the migration and invasion induced by KRT15; overexpression of MMP-7 almost completely rescued the inhibitory effects of KRT15 shRNAs on colorectal cancer cell migration and invasion. In addition, by gain- and loss-of function, we confirmed that β-catenin was responsible for the increased expression of MMP-7 induced by KRT15 colorectal cancer cell lines. In conclusion, KRT15 promotes migration and invasion of colorectal cancer cell at least partly through β-catenin/MMP7 signaling pathway, suggesting KRT15 is a potential therapeutic target for patients with metastatic colorectal cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRef Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRef
2.
Zurück zum Zitat Hong M, et al. IRF1 inhibits the proliferation and metastasis of colorectal cancer by suppressing the RAS-RAC1 pathway. Cancer Manag Res. 2019;11:369–78.CrossRef Hong M, et al. IRF1 inhibits the proliferation and metastasis of colorectal cancer by suppressing the RAS-RAC1 pathway. Cancer Manag Res. 2019;11:369–78.CrossRef
3.
Zurück zum Zitat Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRef
4.
Zurück zum Zitat Waseem A, et al. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol. 1999;112(3):362–9.CrossRef Waseem A, et al. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol. 1999;112(3):362–9.CrossRef
5.
Zurück zum Zitat Lin JB, et al. KRT 15 as a prognostic biomarker is highly expressed in esophageal carcinoma. Future Oncol. 2020;16(25):1903–9.CrossRef Lin JB, et al. KRT 15 as a prognostic biomarker is highly expressed in esophageal carcinoma. Future Oncol. 2020;16(25):1903–9.CrossRef
6.
Zurück zum Zitat Tai G, et al. Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas. PLoS ONE. 2013;8(11):e81167.CrossRef Tai G, et al. Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas. PLoS ONE. 2013;8(11):e81167.CrossRef
7.
Zurück zum Zitat Zhang C, Liang Y, Ma MH, Wu KZ, Dai DQ. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis. Pathol Res Pract. 2019;215(5):893–9.CrossRef Zhang C, Liang Y, Ma MH, Wu KZ, Dai DQ. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis. Pathol Res Pract. 2019;215(5):893–9.CrossRef
8.
Zurück zum Zitat Shan M, et al. Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies. Oncotarget. 2017;8(62):104761–71.CrossRef Shan M, et al. Molecular analyses of prostate tumors for diagnosis of malignancy on fine-needle aspiration biopsies. Oncotarget. 2017;8(62):104761–71.CrossRef
9.
Zurück zum Zitat Khanom R, et al. Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies. Histol Histopathol. 2012;27(7):949–59.PubMed Khanom R, et al. Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies. Histol Histopathol. 2012;27(7):949–59.PubMed
10.
Zurück zum Zitat Zhong P, et al. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma. Exp Ther Med. 2021;21(4):305.CrossRef Zhong P, et al. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma. Exp Ther Med. 2021;21(4):305.CrossRef
11.
Zurück zum Zitat Rao X, Wang J, Song HM, Deng BLi JG. KRT15 overexpression predicts poor prognosis in colorectal cancer. Neoplasma. 2020;67(2):410–4.CrossRef Rao X, Wang J, Song HM, Deng BLi JG. KRT15 overexpression predicts poor prognosis in colorectal cancer. Neoplasma. 2020;67(2):410–4.CrossRef
12.
Zurück zum Zitat Niu J, et al. DKK1 inhibits breast cancer cell migration and invasion through suppression of beta-catenin/MMP7 signaling pathway. Cancer Cell Int. 2019;19:168.CrossRef Niu J, et al. DKK1 inhibits breast cancer cell migration and invasion through suppression of beta-catenin/MMP7 signaling pathway. Cancer Cell Int. 2019;19:168.CrossRef
13.
Zurück zum Zitat Salama AAA, Allam RM. Promising targets of chrysin and daidzein in colorectal cancer: amphiregulin, CXCL1, and MMP-9. Eur J Pharmacol. 2021;892:173763.CrossRef Salama AAA, Allam RM. Promising targets of chrysin and daidzein in colorectal cancer: amphiregulin, CXCL1, and MMP-9. Eur J Pharmacol. 2021;892:173763.CrossRef
14.
Zurück zum Zitat Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix metalloproteinases as new targets in alzheimer’s disease: opportunities and challenges. J Med Chem. 2020;63(19):10705–25.CrossRef Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix metalloproteinases as new targets in alzheimer’s disease: opportunities and challenges. J Med Chem. 2020;63(19):10705–25.CrossRef
15.
Zurück zum Zitat Cabral-Pacheco GA, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.CrossRef Cabral-Pacheco GA, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.CrossRef
16.
Zurück zum Zitat Sun DW, Zhang YY, Qi Y, Zhou XT, Lv GY. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Cancer Epidemiol. 2015;39(2):135–42.CrossRef Sun DW, Zhang YY, Qi Y, Zhou XT, Lv GY. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Cancer Epidemiol. 2015;39(2):135–42.CrossRef
17.
Zurück zum Zitat Gao Y, et al. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation. BMC Cancer. 2019;19(1):685.CrossRef Gao Y, et al. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation. BMC Cancer. 2019;19(1):685.CrossRef
18.
Zurück zum Zitat Gao F, et al. Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP7. Mol Med Rep. 2014;9(3):825–30.CrossRef Gao F, et al. Survivin promotes the invasion of human colon carcinoma cells by regulating the expression of MMP7. Mol Med Rep. 2014;9(3):825–30.CrossRef
19.
Zurück zum Zitat Chen L, Li M, Li Q, Wang CJ, Xie SQ. DKK1 promotes hepatocellular carcinoma cell migration and invasion through beta-catenin/MMP7 signaling pathway. Mol Cancer. 2013;12:157.CrossRef Chen L, Li M, Li Q, Wang CJ, Xie SQ. DKK1 promotes hepatocellular carcinoma cell migration and invasion through beta-catenin/MMP7 signaling pathway. Mol Cancer. 2013;12:157.CrossRef
20.
Zurück zum Zitat Yang X, et al. SULT2B1b promotes epithelial-mesenchymal transition through activation of the beta-catenin/MMP7 pathway in hepatocytes. Biochem Biophys Res Commun. 2019;510(4):495–500.CrossRef Yang X, et al. SULT2B1b promotes epithelial-mesenchymal transition through activation of the beta-catenin/MMP7 pathway in hepatocytes. Biochem Biophys Res Commun. 2019;510(4):495–500.CrossRef
Metadaten
Titel
KRT15 promotes colorectal cancer cell migration and invasion through β-catenin/MMP-7 signaling pathway
verfasst von
Weida Chen
Chengli Miao
Publikationsdatum
01.05.2022
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 5/2022
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-021-01619-2

Weitere Artikel der Ausgabe 5/2022

Medical Oncology 5/2022 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.